Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Giovanni Rossi, Angela Alama, Carlo Genova, Erika Rijavec, Marco Tagliamento, Federica Biello, Simona Coco, Maria Giovanna Dal Bello, Simona Boccardo & Francesco Grossi. (2018) The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy 19:17, pages 1969-1976.
Read now
Read now
Gary Middleton, Cesare Gridelli, Filippo De Marinis, Jean-Louis Pujol, Martin Reck, Rodryg Ramlau, Barbara Parente, Thierry Pieters, Carla M. Visseren-Grul, Bélen San Antonio, William J. John, Annamaria Hayden Zimmermann, Nadia Chouaki & Luis Paz-Ares. (2018) Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. Current Medical Research and Opinion 34:5, pages 865-871.
Read now
Read now
Berrin Küçüktürkmen & Asuman Bozkır. (2018) Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells. Drug Development and Industrial Pharmacy 44:2, pages 306-315.
Read now
Read now
Berrin Küçüktürkmen, Burcu Devrim, Ongun M. Saka, Şükran Yilmaz, Taibe Arsoy & Asuman Bozkir. (2017) Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. Drug Development and Industrial Pharmacy 43:1, pages 12-21.
Read now
Read now
Weiyou Zhu, Oluf Dimitri Røe, Chen Wu, Wei Li, Renhua Guo, Yanhong Gu, Yiqian Liu, Yongqian Shu & Xiaofeng Chen. (2015) Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study. Journal of Chemotherapy 27:4, pages 221-226.
Read now
Read now
Xin Li, Sen Wei & Jun Chen. (2014) Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules. OncoTargets and Therapy 7, pages 937-945.
Read now
Read now
Carlo Genova, Erika Rijavec, Anna Truini, Simona Coco, Claudio Sini, Giulia Barletta, Maria Giovanna Dal Bello, Angela Alama, Grazia Savarino, Paolo Pronzato, Francesco Boccardo & Francesco Grossi. (2013)
Pemetrexed for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy 14:11, pages 1545-1558.
Read now
Read now
M Morotti, M Valenzano Menada, PL Venturini, S Mammoliti & S Ferrero. (2012) Pemetrexed disodium in ovarian cancer treatment. Expert Opinion on Investigational Drugs 21:4, pages 437-449.
Read now
Read now
Articles from other publishers (8)
Maria Joseph, Arun Chandrasekharan & Muhammed Fayiz. (2022) A review of the pharmacokinetic and polymorphic profiles of pemetrexed and their influence on its activity. Cancer Research, Statistics, and Treatment 5:4, pages 785.
Crossref
Crossref
Binsheng He, Jialiang Yang, Geng Tian, Pingping Bing & Jidong Lang. (2021) Detecting TYMS Tandem Repeat Polymorphism by the PSSD Method Based on Next-generation Sequencing. Current Bioinformatics 15:10, pages 1153-1159.
Crossref
Crossref
Wang Chun Kwok, Tan Fong Cheong, Ka Yan Chiang, James Chung Man Ho, David Chi Leung Lam, Mary Sau Man Ip & Terence Chi Chun Tam. (2021) Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. Lung Cancer 152, pages 15-20.
Crossref
Crossref
Zhenyu Pan, Guozi Yang, Jiuwei Cui, Wei Li, Yu Li, Pengxiang Gao, Tongchao Jiang, Yanan Sun, Lihua Dong, Yuanyuan Song & Gang Zhao. (2019) A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer. Frontiers in Oncology 9.
Crossref
Crossref
David Badrudin, Lucas Sideris, Camille Perrault‐Mercier, Julien Hubert, François A. Leblond & Pierre Dubé. (2018) Comparison of open and closed abdomen techniques for the delivery of intraperitoneal pemetrexed using a murine model. Journal of Surgical Oncology 117:6, pages 1318-1322.
Crossref
Crossref
Li‐Yan Zhou, Ye‐Hui Shi, Yong‐Sheng Jia & Zhong‐Sheng Tong. (2015) Potential role of pemetrexed in metastatic breast cancer patients pre‐treated with anthracycline or taxane. Chronic Diseases and Translational Medicine 1:1, pages 27-35.
Crossref
Crossref
Jan Nyrop Jakobsen, Eric Santoni-Rugiu & Jens Benn Sørensen. (2014) Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology 140:4, pages 645-652.
Crossref
Crossref
Young Saing Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn & Keunchil Park. (2013) The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer. Lung Cancer 81:2, pages 231-235.
Crossref
Crossref